Markets
Designed for the world’s highest-value healthcare and research economies.
Initial market prioritization focuses on research density, healthcare expenditure, AI adoption, institutional acquisition potential and regulatory readiness.
Request Enterprise Access →United States
Highest priority market for enterprise, research and AI healthcare adoption.
European Union
Strong regulatory maturity, clinical networks and public health infrastructure.
United Kingdom
High-value AI health ecosystem with strong institutional partnerships.
Japan
Advanced healthcare system, aging population and neurodevelopmental research demand.
Australia & Canada
High trust healthcare environments with strong digital health readiness.
Brazil & Latin America
Large emerging market with regional scale and high demand for early detection tools.